HFNC Versus Microstream Advance Nasal Cannula for Oxygenation During ERCP

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-84
SponsorKocaeli University

About this trial

Endoscopic retrograde cholangiopancreatography (ERCP) procedures are commonly performed under deep sedation and are associated with a risk of hypoxemia, particularly in prone or semi-prone positions. High-flow nasal cannula (HFNC) therapy may improve oxygenation by delivering heated and humidified oxygen at high flow rates, while the Microstream Advance nasal cannula provides simultaneous nasal oxygen delivery and oral oxygen insufflation.

This prospective randomized study aims to compare the effectiveness of HFNC and Microstream Advance nasal cannula in maintaining oxygenation during ERCP procedures. Patients undergoing ERCP will be randomized into two groups receiving either HFNC or Microstream Advance nasal cannula oxygen support during sedation.

The primary outcomes are the incidence of desaturation and oxygen reserve index (ORi) measurements during the procedure. Secondary outcomes include time to achieve target ORi levels, respiratory complications, and procedure-related adverse events.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18 to 84 years

ASA physical status I-III

Patients scheduled to undergo ERCP

Patients who provide written informed consent

Disqualifiers

Recent history of upper respiratory tract infection

History of lung cancer

Chronic obstructive pulmonary disease

Asthma

Trial design

Design model

Parallel

Treatments tested in this trial

  • High-flow nasal canula

    Device

    Heated and humidified high-flow oxygen therapy delivered through a nasal cannula during ERCP under sedation

  • Microstream advance nasal cannula

    Device

    Oxygen support delivered through the Microstream Advance nasal cannula during ERCP under sedation.

Treatment groups

74 Participants
are divided into 2 treatment groups
Group A: HFNC GroupExperimental treatment 1 intervention
Group B: Microstream Advance Nasal Cannula GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of Desaturation During ERCP

Comparison of the frequency of oxygen desaturation episodes between HFNC and Microstream Advance nasal cannula groups during ERCP under sedation.

Time frame
During the ERCP procedure

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.